Since NF-κB is one of the crucial cytokines involved in the crosstalk between TAMs and tumor cell EMT, targeting NF-κB signaling has become an intensely studied strategy for treating TAM-related tumor metastasis. Here, NFKB1 is linked to neoplasm.